Literature DB >> 7679160

Predominant alpha 1-adrenoceptor-mediated contraction in the human internal mammary artery.

G W He1, J Shaw, C F Hughes, C Q Yang, D S Thomson, B McCaughan, P N Hendle, D K Baird.   

Abstract

alpha-Adrenoceptor agonists and antagonists are widely used perioperatively for internal mammary artery (IMA)-coronary artery bypass operations. To determine subtypes of alpha-adrenoceptors in the human IMA, we studied responses of isolated human IMA segments to alpha-adrenoceptor agonists, antagonists, and electrical stimulation in organ baths. The IMA ring segments (3 mm long) were set up at a physiologic and comparable condition according to their own length-tension curves. alpha 1-Agonist methoxamine (MO) induced 2.65 +/- 0.70 g force and alpha 1, alpha 2-agonist norepinephrine (NE) induced 4.07 +/- 0.70 g force. The contractions induced by both MO and NE were totally abolished by alpha 1-antagonist prazosin (0.1 microM) but not alpha 2-antagonist yohimbine. alpha 2-Agonist UK14304 induced only 0.39 +/- 0.17 g force, which was significantly less than that induced by MO or NE (p < 0.001). Contractions induced by electrical field stimulation (2, 10, 20 Hz) were decreased by alpha 1-antagonist prazosin 1 microM (p < 0.01) but potentiated by alpha 2-antagonist yohimbine. These results strongly suggest that in the human IMA the postjunctional alpha-adrenoceptors are predominantly of the alpha 1-subtype and therefore the alpha-adrenoceptor agonist-induced contraction and the sympathetic nerve stimulation-induced contraction is mediated mainly by activation of the alpha 1-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679160

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Arterial grafts: clinical classification and pharmacological management.

Authors:  Guo-Wei He
Journal:  Ann Cardiothorac Surg       Date:  2013-07

2.  Sex differences in vascular reactivity of coronary artery bypass graft conduits.

Authors:  Amenah Jaghoori; Victor Lamin; Rachel Jacobczak; Michael Worthington; James Edwards; Fabiano Viana; Robert Stuklis; David P Wilson; John F Beltrame
Journal:  Heart Vessels       Date:  2019-10-01       Impact factor: 2.037

3.  Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.

Authors:  M H Liu; S H Floten; Q Yang; G W He
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

4.  Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries.

Authors:  R S Garcha; P S Sever; A D Hughes
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

5.  Inhibitory effects of calcium antagonists on alpha-adrenoceptor-mediated contraction in the human internal mammary artery.

Authors:  G W He; T E Acuff; W H Ryan; C Q Yang; M B Douthit; R T Bowman; M J Mack
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

6.  Interaction between endothelin and vasodilators in the human internal mammary artery.

Authors:  G W He; C Q Yang; M J Mack; T E Acuff; W H Ryan; A Starr
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

7.  Arterial segments as microvascular interposition grafts in venous anastomosis in digital replantations.

Authors:  Shiv Shankar Saha; Anurag Pandey; Chirayu Parwal
Journal:  Indian J Plast Surg       Date:  2015 May-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.